The Board of directors of IBN Sina Pharmaceutical Industry Limited has recommended 25 per cent cash dividend and 10 per cent stock dividend for the year ended on June 30, 2017.
The final approval will come during the Annual General Meeting (AGM) scheduled to be held on November 22 at 9:30am at Rifles Square, Dhanmondi in Dhaka, said an official disclosure on Tuesday.
The record date for entitlement of dividend is on October 22.
The company has reported earnings per share (EPS) of Tk 9.06, net operating cash flow per share (NOCFPS) of Tk 4.82 and net asset value (NAV) per share of Tk 42.79 for the year ended on June 30, 2017 as against Tk. 7.85, Tk. 33.67 and Tk. 14.92 respectively for the same period of the previous year.
There will be no price limit on the trading of the shares of the company today following the corporate declaration, according to DSE website.
The IBN Sina was listed on the Dhaka bourse in 1989. The company belongs to “A” category.